Company Filing History:
Years Active: 1993
Title: Joelle Arnaud: Innovator in Cardiovascular Treatment
Introduction
Joelle Arnaud is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular disorders. Her innovative work has led to the development of valuable compounds that can potentially improve patient outcomes.
Latest Patents
Joelle Arnaud holds 1 patent for her invention titled "N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders." This patent describes non-peptide compounds that oppose the action of angiotensin II, making them useful in treating conditions such as hypertension and heart failure. The processes for their preparation and the pharmaceutical compositions containing these compounds are also detailed in her patent.
Career Highlights
Throughout her career, Joelle has worked with Elf Sanofi, a leading French corporation in the pharmaceutical industry. Her role at the company has allowed her to focus on research and development, contributing to advancements in medical treatments.
Collaborations
Joelle has collaborated with notable colleagues, including Jean-Louis Assens and Claude Bernhart. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.
Conclusion
Joelle Arnaud's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to cardiovascular treatment through her patented compounds highlight the importance of research and collaboration in advancing medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.